Company Filing History:
Years Active: 1989-1991
Title: The Innovations of Peter J Sadler
Introduction
Peter J Sadler is a notable inventor based in Harrow Weald, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that inhibit tumor cell growth. With a total of two patents to his name, Sadler's work has implications for cancer treatment and medical imaging.
Latest Patents
Sadler's latest patents include a tumor cell growth-inhibiting pharmaceutical composition. This composition contains a bis[bis(diphenylphosphino)hydrocarbon] complex, which is designed to inhibit the growth of tumor cells in afflicted animals. Another significant patent involves a contrast agent for NMR scanning. This agent is formed from complexes between an amino di- or poly-phosphonate and a paramagnetic metal ion, such as Gd³⁺. These complexes have properties that make them useful for investigating bone metabolism through NMR scanning.
Career Highlights
Throughout his career, Peter J Sadler has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Amersham International Plc and SmithKline Beecham Corporation. His work in these organizations has contributed to advancements in medical research and drug development.
Collaborations
Sadler has collaborated with esteemed colleagues, including Charles T Harding and James D Kelly. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Peter J Sadler's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to influence cancer treatment and medical imaging technologies.